Regenicin, Inc.
RGIN
Rank in Stocks
#34320
Regenicin, Inc. is dedicated to the development and commercialization of... Regenicin, Inc. is dedicated to the development and commercialization of advanced tissue-engineered skin replacement technologies. Its product line features NovaDerm, a sophisticated multi-layered living and cultured skin substitute engineered for treating burn injuries, alongside TempaDerm, which addresses more localized wound areas like ulcers. These innovative solutions aim to rejuvenate the characteristics of healthy human skin, finding application in burn therapy, chronic wound management, and various plastic surgery procedures. Incorporated in 2007 and based in Little Falls, New Jersey, the company was previously known as Windstar, Inc., adopting the Regenicin, Inc. name in July 2010.
Share Price
$0.0001
Last synced: 2026-11-13
Market Cap
$15.35K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
Stock data: Financial Modeling PrepยทUpdated ยทNot investment adviceยทHow we calculate this
Trade Regenicin, Inc. (RGIN)
Category
Healthcare
EPS for Regenicin, Inc. (RGIN)
EPS as of March 2023 TTM: $-0.01
According to Regenicin, Inc.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2022 the company had an EPS of 0.00, equal to its 2021 EPS of 0.00.
EPS history for Regenicin, Inc. from 2007 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -6.25% |
| 2022 | 0.00 | -6.25% |
| 2021 | 0.00 | 17.07% |
| 2020 | 0.00 | -19.61% |
| 2019 | $-0.01 | 41.67% |
| 2018 | 0.00 | -42.86% |
| 2017 | $-0.01 | -11.27% |
| 2016 | $-0.01 | -543.75% |
| 2015 | 0.00 | -84.00% |
| 2014 | $0.01 | -123.36% |
| 2013 | $-0.04 | 16.94% |
| 2012 | $-0.04 | -15.47% |
| 2011 | $-0.04 | 249.19% |
| 2010 | $-0.01 | 6,100.00% |
| 2009 | 0.00 | -66.67% |
| 2008 | 0.00 | 500.00% |
| 2007 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -241,023.08% |
US
|
|
| $-7.07 | 108,669.23% |
US
|
|
| $-5.29 | 81,284.62% |
AU
|
|
| $12.73 | -195,980.00% |
BE
|
|
| $21.56 | -331,792.31% |
NL
|
Questions about Regenicin, Inc.'s earnings per share (EPS)
What is Regenicin, Inc.'s earnings per share (EPS)?
Regenicin, Inc.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Mar 2023.
What was Regenicin, Inc.'s earnings per share (EPS) in 2022?
In 2022, Regenicin, Inc.'s earnings per share (EPS) was 0.00, compared with 0.00 in 2021.
How has Regenicin, Inc.'s earnings per share (EPS) changed since 2017?
From 2017 to 2022, Regenicin, Inc.'s earnings per share (EPS) was highest in 2022 (0.00) and lowest in 2019 ($-0.01).
How does Regenicin, Inc.'s earnings per share (EPS) compare with similar companies?
Regenicin, Inc.'s earnings per share (EPS) ($-0.01) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.